HGH Plus (Life Choice Ltd.)


Welcome to the PulseAid listing for the HGH Plus drug offered from Life Choice Ltd.. This Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Insulin [Chemical/Ingredient],Insulin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Life Choice Ltd.
NON-PROPRIETARY NAME: Adrenalinum, Thyroidinum (suis), Insulinum, Pituitaria Glandula (suis),
SUBSTANCE NAME: EPINEPHRINE; SUS SCROFA THYROID; INSULIN HUMAN; SUS SCROFA PITUITARY GLAND
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Insulin [Chemical/Ingredient],Insulin [EPC]
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-03-10
END MARKETING DATE: 0000-00-00


HGH Plus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHGH Plus from Life Choice Ltd.
LABELER NAME: Life Choice Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 9; 9; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL)
START MARKETING DATE: 2014-03-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55856-0003_186066ab-3f6f-400a-bb08-aec56b7f1af5
PRODUCT NDC: 55856-0003
APPLICATION NUMBER:

Other EPINEPHRINE; SUS SCROFA THYROID; INSULIN HUMAN; SUS SCROFA PITUITARY GLAND Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Life Choice Ltd.HGH Plus